Project Grant HT94252510222
Award Date
5/1/25
Completion Date
10/31/25
Dollars Obligated
$533K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Burlingame, CA 94010, USA
Similar Awards
The U.S. Defense Health Agency awarded a $3,024,000 Project Grant to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, to develop a practical form of hypoxia therapy for mitochondrial diseases such as 3-MGA. This grant is funded through the Department of the Army's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health of military service members, veterans, and their families....
The Department of the Army Medical Command awarded a $5,599,536 Project Grant (CFDA 12.420 - Military Medical Research and Development) to Senseer Health Inc. of Pasadena, CA. The grant, running from June 1, 2024 to May 31, 2028, will fund the development of multimodal diagnostic microsensors for monitoring the status of hydrocephalus shunts. This research aims to transform healthcare for military service members and the broader public by advancing innovative medical technologies. The Military...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The federal Project Grant award of $860,998.00 was issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from April 1, 2025 to March 31, 2028, supports neurophysiology research focused on understanding the epileptogenesis signals and biomarkers underlying post-traumatic epilepsy. This research, conducted by the Regents of the University of California, San Francisco (UCSF), aims to...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
The Department of the Army Medical Command awarded a $750,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Leland Stanford Junior University. The grant, which runs from September 1, 2024 to August 31, 2027, will fund the implementation of a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. This research, to be conducted at Stanford University, aims to transform...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
This $3,800,334 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund The Regents of the University of Colorado to conduct research to improve maternal mental health in military-affiliated pregnant women through the effectiveness of a smart bassinet intervention. The project will run from June 2024 to June 2028 and aims to develop and evaluate an innovative technological solution to address mental health...
This federal Project Grant award, with an ID of HT94252410742, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $3,837,128 award was made on July 1, 2024, with a completion date of June 30, 2029. The grant funds research on magnetic resonance analysis of neural inflammatory factors and external stimulation, with a focus on transforming healthcare for military service members and the broader public. The prime awardee is the...
The Department of the Army Medical Command awarded a $520,751 Project Grant to the Veteran Research And Education Foundation Of ST Louis through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2026 to improve outcomes for prostate cancer patients based on comorbidities, with the goal of developing personalized medicine approaches. Through this award, the Foundation will conduct research to investigate medical...